Search Content | UT Health San Antonio MD Anderson Cancer Center

Search Result for "*:*"

Condition

Lung Cancer

Condition

Bone Cancer

Condition

Pancreatic Cancer

San Antonio Firefighters Cancer Prevention Program

provider

Travis Forney, PA-C, MPAS, BSN Hematology-Oncology

provider

Rajat Garg, MD Advanced Interventional Gastroenterology, Pancreas and Liver

Research & Publications

Platinum Doublet plus Atezolizumab as First-line Treatment in Metastatic Large Cell Neuroendocrine Carcinoma: A Single Institution Experience

Research & Publications

Aphase1a/ 1bfirst-in-human, open-label, dose-escalation, safety, pharmacokinetic, and pharmacodynamic study of oral TP-0903, a potent inhibitor of AXL kinase, administered daily for 21 days to patients with advanced solid tumors.

Research & Publications

The Role of Genetics in sporadic GEP-NETs: A Comprehensive Review of the Literature

Research & Publications

Aphase1a/ 1bfirst-in-human, open-label, dose-escalation, safety, pharmacokinetic, and pharmacodynamic study of oral TP-0903, a potent inhibitor of AXL kinase, administered daily for 21 days to patients with advanced solid tumors.